Highline SCIENCES

San Francisco, United States Founded: 2018 • Age: 8 yrs Acquired By Tempus
CRO focused on clinical development services for oncology drugs

About Highline SCIENCES

Highline SCIENCES is a Healthcare company based in San Francisco (United States) founded in 2018, and was acquired by Tempus in February 2022. CRO focused on clinical development services for oncology drugs. Highline SCIENCES offers products and services including CRO Services and Consultancy Services. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Aster Insights, OnCusp and CancerVax; 3 of its 3 listed competitors have raised funding.

Company details

Highline Sciences was founded in 2018 and is headquartered in San Francisco, United States. As a contract research organization (CRO), focus is placed on clinical development services specifically for oncology drugs. Operations encompass trial design, regulatory support, and data management tailored to pharmaceutical partners in the biotechnology sector. Services are delivered across various phases of drug development, with an emphasis on oncology therapeutics in the North American market.

Key Metrics

Products & Services of Highline SCIENCES

Highline SCIENCES offers a comprehensive portfolio of products and services, including CRO Services and Consultancy Services.

CRO Services
Research Services

Full-service contract research for oncology biotech firms and clients.

Consultancy Services
Advisory Services

Bespoke consultancy to address gaps in traditional biotech operations.

Investors in Highline SCIENCES

Highline SCIENCES has secured backing from 1 investor. Prominent investors backing the company include Tempus.

All
InvestorDescriptionFounded YearDomainLocation
AI-based precision medicine solutions for oncology are provided.
2015tempus.comChicago, United States
Premium access

Investor details for Highline SCIENCES

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Highline SCIENCES

3 people are tracked at Highline SCIENCES (1 in leadership, 2 in team).

NameRoleGroup
Collin Williams
Founder & Chief Executive OfficerLeadership
Susan Refice
Clinical Project ManagerTeam
Eric Easter
Sr. Clinical Research AssociateTeam
Premium access

Complete people profiles for Highline SCIENCES

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Highline SCIENCES

2 dated milestones of Highline SCIENCES across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Highline SCIENCES is founded.
  2. Exit Acquired by Tempus.

Competitors of Highline SCIENCES

Highline SCIENCES has 3 listed competitors in our database, 3 of them funded. They include Aster Insights, OnCusp and CancerVax.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asterinsights.com2006Tampa, United States$75M115
Contract-based oncology clinical trial services are provided by Aster Insights.
oncusptx.com2021New York, United States$100M
CRO offering clinical development services for oncology drugs
cancervax.com1998Carlsbad, United States$55M
Cancer vaccine research and development is conducted by CancerVax.
Premium access

Detailed competitors of Highline SCIENCES

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Highline SCIENCES (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Highline Sciences

Premium access

Complete news archive for Highline SCIENCES

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Highline SCIENCES

Highline SCIENCES was founded in 2018.

Highline SCIENCES is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Highline Sciences was founded in 2018 and is headquartered in San Francisco, United States. As a contract research organization (CRO), focus is placed on clinical development services specifically for oncology drugs. Operations encompass trial design, regulatory support, and data management tailored to pharmaceutical partners in the biotechnology sector. Services are delivered across various phases of drug development, with an emphasis on oncology therapeutics in the North American market.

Highline SCIENCES's top competitors include CancerVax, OnCusp and Aster Insights.

Highline SCIENCES offers CRO Services and Consultancy Services.

Highline SCIENCES has 1 investor. Key investors include Tempus.

Yes. Highline SCIENCES was acquired by Tempus in February 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available